METTL3 expression based on
|
Comparison | Statistical significance |
Normal-vs-Primary | 5.55990031791964E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.52240000500714E-08 |
Normal-vs-Stage2 |
8.08790000000892E-05 |
Normal-vs-Stage3 |
1.03519970373611E-10 |
Normal-vs-Stage4 |
2.74779999998032E-06 |
Stage1-vs-Stage2 |
7.175800E-01 |
Stage1-vs-Stage3 |
1.347750E-02 |
Stage1-vs-Stage4 |
2.755200E-01 |
Stage2-vs-Stage3 |
2.075400E-01 |
Stage2-vs-Stage4 |
6.248000E-01 |
Stage3-vs-Stage4 |
5.114200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.02869995749688E-09 |
Normal-vs-AfricanAmerican |
9.52239999999493E-05 |
Normal-vs-Asian |
4.760300E-03 |
Caucasian-vs-AfricanAmerican |
8.101600E-01 |
Caucasian-vs-Asian |
3.973600E-02 |
AfricanAmerican-vs-Asian |
9.870200E-02 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.2080999957127E-08 |
Normal-vs-Female |
1.5212999748826E-09 |
Male-vs-Female |
8.677400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.22550000036803E-07 |
Normal-vs-Age(41-60Yrs) |
5.27600000355122E-08 |
Normal-vs-Age(61-80Yrs) |
6.73330002864958E-09 |
Normal-vs-Age(81-100Yrs) |
2.043500E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.771400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.651600E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.231600E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.144220E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.756610E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.651200E-01 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Classical-VS-Tall |
1.78544999999142E-05 |
Classical-VS-Follicular |
3.526200E-01 |
Classical-VS-Other |
9.991800E-01 |
Classical-VS-Normal |
3.55389999651123E-08 |
Tall-VS-Follicular |
4.997000E-03 |
Tall-VS-Other |
1.801230E-01 |
Tall-VS-Normal |
1.79569692448922E-11 |
Follicular-VS-Other |
7.733800E-01 |
Follicular-VS-Normal |
3.68559999996965E-06 |
Other-VS-Normal |
5.532400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.88379994831212E-09 |
Normal-vs-N1 |
7.035600E-04 |
N0-vs-N1 |
3.803400E-01 |
|
|